Search for: "Smith v. Mylan Inc."
Results 21 - 40
of 48
Sorted by Relevance
|
Sort by Date
7 Nov 2014, 5:52 am
Teva Pharmaceuticals USA, Inc., 819 F. [read post]
12 Jan 2016, 11:39 am
Apotex Inc., No. 15-281 Mylan Pharmaceuticals Inc. v. [read post]
17 Mar 2015, 9:33 am
Smith v. [read post]
16 Dec 2009, 3:39 am
: Ariad Pharmaceuticals, Inc. v. [read post]
17 Feb 2016, 9:20 am
Apotex Inc., No. 15-281 Mylan Pharmaceuticals Inc. v. [read post]
25 Jan 2007, 12:48 am
Friedlander, 103 F.3d 1105, 1113 (2d Cir. 1997); Mylan Laboratories, Inc. v. [read post]
20 Oct 2010, 1:20 pm
Mylan, Inc., 2010 WL 2008797, slip op. [read post]
18 Jan 2013, 2:06 pm
This post is by the Reed Smith part of the blog only. [read post]
3 May 2016, 1:42 am
BriarTek IP, Inc. v. [read post]
18 May 2016, 8:19 am
Attorney Fees: Newegg Inc. v. [read post]
1 Apr 2016, 8:22 am
Design Patents: Systems, Inc. v. [read post]
17 Mar 2016, 2:45 am
Smith & Nephew, Inc., et al., No. 15-559 (Commil re-hash – if actions were “not objectively unreasonable&rdqu [read post]
28 Mar 2014, 5:33 pm
Category: Infringement By: Eric Paul Smith, Contributor TitlePfizer Inc. v. [read post]
12 Mar 2018, 2:00 am
Pimlico Plumbers Ltd & Anor v Smith, heard 20-21 Feb 2018. [read post]
7 Sep 2011, 4:22 am
(Kluwer Patent Blog) Fortical (Calcitonin-salmon) – US: Obviousness in chemical formulations: (unclaimed) purpose of limitation leads to nonobviousness holding: Unigene Labs. and Upsher-Smith Labs v. [read post]
2 Mar 2012, 6:52 am
Bard, Inc. [read post]
6 Mar 2014, 12:41 pm
Glaxo Smith Kline Healthcare, 2006 WL 952032 (N.D. [read post]
28 Jun 2016, 6:41 am
Design Patents: Systems, Inc. v. [read post]
17 Mar 2020, 1:32 pm
Fluid Administration Set have been recalled by Smiths Medical ASD, Inc. due to the potential exposure to toxic levels of aluminum. [read post]
8 Aug 2018, 11:15 pm
Mylan Pharmaceuticals, Inc. [read post]
